In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Armkel

This article was originally published in The Rose Sheet

Executive Summary

Depilatory and skin care sales up 3% to $27.5 mil. in second quarter, firm reports in 10Q filed with the Securities and Exchange Commission Aug. 8. Increase is led by 14% gain in Nair sales for the period (1"The Rose Sheet" Aug. 12, 2002, p. 5). Sales for smallest Armkel product category, oral care (Pearl Drops), soared 21% to $8.9 mil. for quarter. Results for the 50/50 Church and Dwight/Kelso & Co. partnership formed to purchase most Carter-Wallace consumer products are compared to C-W for previous year. Armkel total net sales advanced 1.8% to $115.9 mil. in Q2...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010530

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel